Effects of human immunodeficiency virus type 1 infection on programmed cell death in the presence or absence of Bcl-2

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 12, Issue 4, 1996, Pages 321-328

  Park, In Woo ^b   Kondo, Eisaku ^b   Bergeron, Louise ^b   Park, Jinseu ^b   Sodroski, Joseph ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b NONE

Author keywords

Apoptosis; Bcl 2; HIV 1; Jurkat cell; Programmed cell death

Indexed keywords

ACRIDINE ORANGE; CD4 ANTIGEN; ETHIDIUM BROMIDE;

APOPTOSIS; ARTICLE; CELL DEATH; CYTOLYSIS; CYTOPATHOGENIC EFFECT; GENE EXPRESSION; GIEMSA STAIN; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEUKEMIA CELL LINE; LYMPHOCYTE COUNT; PRIORITY JOURNAL; PROTEIN PROCESSING; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 9544230790     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199608010-00001     Document Type: Article

References (42)

1. Barre-Sinoussi F, Chermann JC, Rey F, et al. Isolation of a T-lymphocyte retrovirus from a patient at risk for acquired immunodeficiency syndrome (AIDS). Science 1983;220:88-871.
2. Fauci A, Macher A, Longo D, et al. Acquired immunodeficiency syndrome: epidemiologic, clinical, immunologic, and therapeutic considerations. Ann Intern Med 1984;100:92-106.
3. Gallo RC, Salahuddin SZ, Popovic M, et al. Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science 1984; 224:500-3.
4. Fauci AS. The human immunodeficiency virus: infectivity and mechanisms of pathogenesis. Science 1988;239:617-22.
5. Patterson S, Roberts MS, English NR, et al. Detection of HIV DNA in peripheral blood dendritic cells of HIV-1-infected individuals. Res Virol 1994;145:171-6.
6. Cao Y, Qin L, Zhang J, Safrit JT, Ho DD. Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. N Engl J Med 1995;332:201-8.
7. Connor RI, Mohri H, Cao Y, Ho DD. Increased viral burden and cytopathicity correlate temporally with CD4+ T-lymphocyte decline and clinical progression in human immunodeficiency virus type 1-infected individuals. J Virol 1993;67: 1772-7.
8. Ho DD, Moudgil T, Alam M. Quantitation of HIV-1 in the blood of infected persons. N Engl J Med 1989;3211:1621-5.
9. Pantaleo G, Graziosi C, Demarest JF, et al. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 1993;362:355-8.
10. Ho DD, Neumann A, Perelson A, Chen W, Leonard J, Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1955;373:123-9.
11. Wei X, Ghosh S, Taylor M, et al. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 1995;373: 117-22.
12. Korp RA, Safrit JT, Cao Y, et al. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J Virol 1994;68:4640-55.
13. Muro-Cacho, CA, Pantaleo G, Fauci AS. Analysis of apoptosis in lymph nodes of HIV-infected persons. Intensity of apoptosis correlates with the general state of activation of the lymphoid tissue and not with stage of disease or viral burden. J Immunol 1995;154:5555-6.
14. Gougeon ML, Laurent-Crawford AG, Hovanessian AG, Montagnier L. Direct and indirect mechanisms mediating apoptosis during HIV infection: contribution to in vivo CD4 T cell depletion. Semin Immunol 1993;5:187-94.
15. Finkel TH, Tudor-Williams G, Banda NK, et al. Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes. Nat Med 1995;1:129-34.
16. Laurent-Crawford AG, Reviere Y, Desgranges C, et al. Membrane expression of HIV envelope glycoproteins triggers apoptosis in CD4 cells. AIDS Res Hum Retroviruses 1993;9:761-73.
17. Terai C, Kornbluth RS, Pauza CD, Richman DD, Carson DA. Apoptosis as a mechanism of cell death in cultured T lymphoblasts acutely infected with HIV-1. J Clin Invest 1991;85:1710-17.
18. DeRossi A, Franchini F, Aldovini A, et al. Differential response to the cytopathic effects of human T-cell lymphotropic virus type III (HTLV-III) superinfection in T4+ (helper) and T8+ (suppressor) T-cell clones transformed by HTLV-1. Proc Natl Acad Sci USA 1986;83:4297-4301.
19. Dalgleish AG, Beverley PCL, Clapham PR, Crawford DH, Greaves MF, Weiss RA. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 1984;312:763-7.
20. Klatzmann D, Champagne E, Chamaret S, et al. T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature 1984;312:767-8.
21. Popovic M, Sarngadharan M, Read E, Gallo R. A method for detection, isolation, and continuous production of cytopathic human T-lymphotropic retroviruses of the HTLV family (HTLV-III) from patients with AIDS and pre-AIDS. Science 1994;224:497-500.
22. Somasundaran M, Robinson HL. A major mechanism of human immunodeficiency virus-induced cell killing does not involve cell fusion. J Virol 1987;61:3114-19.
23. Lifson JD, Feinberg MB, Reyes GR, et al. Induction of CD4-dependent cell fusion by the HTLV-III/LAV envelope glycoprotein. Nature 1986;323:725-8.
24. Sodroski J, Goh WC, Rosen CA, Campbell K, Haseltine W. Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity. Nature 1986;322:470-4.
25. Cao J, Park I-W, Cooper A, Sodroski J. Molecular determinants of acute single cell lysis by human immunodeficiency virus (HIV-1). J Virol 1996;70:1340-54.
26. Vaux DL, Suzanne C, Adams JM. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 1988;335:440-2.
27. Tsujimoto Y. Overexpression of the human BCL-2 gene product results in growth enhancement of Epstein-Barr virus-immortalized B cells. Proc Natl Acad Sci USA 1989;86: 1958-62.
28. Nunez GL, London L, Hochenbery D, Alexander M, McKearn JP, Korsmeyer SP. Regulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines. J Immunol 1990;144:3602-10.
29. Vaux DL. Toward an understanding of the molecular mechanisms of physiological cell death. Proc Natl Acad Sci USA 1993;90:786-9.
30. Itoh N, Tsujimoto Y, Nagata S. Effect of Bcl-2 on Fas antigen-mediated cell death. J Immunol 1993;151:621-7.
31. Miura A, Zhu H, Rotello R, Hartweig EA, Yuan J. Induction of apoptosis in fibroblasts by IL-1β-converting enzyme, a mammalian homology of the C. elegans cell death gene CED3. Cell 1993;75:653-60.
32. Gabuzda DH, Li H, Lawrence K, Vasir BS, Crawford K, Langhoff E. Essential role of vif in establishing productive HIV-1 infection in peripheral blood T lymphocytes and monocyte/macrophages. J Acquir Immune Defic Syndr 1994;7:908-15.
33. Kondo E, Yoshino T, Yamadori I, et al. Expression of the Bcl-2 protein and Fas antigen in non-Hodgkin's lymphoma. Am J Pathol 1994;145:330-7.
34. Helseth E, Kowalski M, Gabuzda D, Olshevsky U, Haseltine W, Sodroski J. Rapid complementation assays measuring replicative potential of human immunodeficiency virus type 1 envelope glycoprotein mutants. J Virol 1990;64:2416-20.
35. Wittekind D. On the nature of Romanowsky dyes and the Romanowsky-Giemsa effect. Clin Lab Haematol 1979;1: 247-62.
36. McDougal JS, Kennedy K, Sligh J, Cort S, Mowie A, Nicholson J. Binding of the HTLV-III/LAV to T4 + T cells by a complex of the 100 K viral protein and the T4 molecule. Science 1986;231:382-5.
37. McDougal JS, Nicholson J, Cross G, Cort S, Kennedy M, Mawle A. Binding of the human retrovirus HTLVIII/LAV/ ARV/HIV to the CD4 (T4) molecule: conformation dependence, epitope mapping, antibody inhibition, and potential for idiotypic mimicry. J Immunol 1986;137:2937-44.
38. Bergeron L, Sodroski J. Dissociation of unintegrated viral DNA accumulation from single-cell lysis induced by human immunodeficiency virus type 1. J Virol 1992;66:5777-87.
39. Kowalski M, Bergeron L, Dorfman T, Haseltine W, Sodroski J. Attenuation of human immunodeficiency virus type 1 cytopathic effect by a mutation affecting the transmembrane envelope glycoprotein. J Virol 1991;65:281-91.
40. Levine B, Huang Q, Isaacs JT, Reed JC, Griffin DE, Hardwick JM. Conversion of lytic to persistent alphavirus infection by the bcl-2 cellular oncogene. Nature 1993;361:739-42.
41. Hinshaw VS, Olsen CW, Dybdahl-Sissoko N, Evans D. Apoptosis: a mechanism of cell killing by influenza A and B viruses. J Virol 1994;68:367-73.
42. Alnemri ES, Robertson NM, Fernandes TF, Croce CM, Litwack G. Overexpressed full-length human BCL2 extends the survival of baculovirus-infected Sf9 insect cells. Proc Natl Acad Sci USA 1992;89:7295-9.